Delaguerre 2022.
Methods | Prospective, open‐label, non‐inferiority randomised (2:1), controlled trial |
Participants | Study included healthy individuals aged 18 to 45 years, with negative RADT test 3 days prior to concert event, with no risk factors and not living with someone with risk factors, and residing in Paris. Study excluded people with positive RADT test within 3 days before the gathering. People with clinical signs suggestive of an infectious respiratory disease, or with risk factor for severe COVID‐19, or living with someone with risk factors for severe COVID‐19. Persons not covered by French National Health Insurance or who cannot stand for the duration of the experiment (about 5 hours from entry line to exit) were excluded. Person under legal guardianship, pregnant woman or woman orally declaring non‐use of effective contraception and breastfeeding woman were also excluded. |
Interventions | Participants were randomly assigned to:
Both groups had RADT test 3 days before the event Saliva samples for RT‐PCR were collected from both groups on D0 and D7 using self‐saliva‐collection kits |
Outcomes | Primary outcome:
Secondary outcomes:
|
Notes |
|